Phenotypic characterization of an ATP13A2 knockout rat model of Parkinson’s disease
Objective: This project aimed to characterize the first-ever transgenic ATP13A2 knockout rat model to elucidate the underlying mechanisms of ATP13A2-associated pathology. Background: Most Parkinson’s disease…Association Between Glycated Hemoglobin (HbA1c) Levels And Motor Symptoms In Indian Subjects With Parkinson’s Disease: A Cross Sectional Observational Study
Objective: India is known for its diversity and genetic heterogeneity and our research seeks to fill the current gap in understanding how glycated hemoglobin (HbA1c)…Effects of Sample Collection Methods on Skin Sebum Volatilome Composition in Parkinson’s Disease Patients – a Methodological Pilot Study
Objective: To assess replicability of skin sebum volatile organic compound (VOC) composition 1) within the same subjects; 2) in frozen vs fresh samples, and 3)…Movement disorders in patients with central nervous system tuberculosis: A systematic review
Objective: We conducted a critical review of the literature on movement disorders (MD) in patients with central nervous (CNS) tuberculosis (TB), with the goal of…Identifying Barriers and Facilitators to Accessing Care for Members of the Black Diaspora and Hispanic People Affected by Parkinson Disease: A Qualitative Study
Objective: To identify barriers and facilitators to care for members of the Black Diaspora (MBD) and Hispanic people affected by Parkinson Disease (PD). To identify…Vegetables and fruits to relieve constipation: Do Parkinson’s disease patients know them?
Objective: To compare the knowledge of vegetables and fruits for treating constipation between PD and non-PD patients with constipation. Background: Constipation is a common non-motor…Real-World Retrospective Safety Analysis in Patients Treated With OnabotulinumtoxinA for Multiple Therapeutic Indications Over Repeat Treatment Periods
Objective: To evaluate the real-world safety of onabotulinumtoxinA (onabotA) use over repeat treatment periods (TPs) in patients (pts) with concomitant multiple therapeutic indications. Background: In…Movement Disorders in Anti-IGLON5 Antibody Disease
Objective: To review demographic, clinical features, treatment trends, and responses in Anti-IgLON5 disease with a focus on movement disorders Background: Anti-IgLON5 antibody disease has emerged…Instrument-supported Gait Analysis Characterizes Gait Domain Changes in Patients with Suspected Normal Pressure Hydrocephalus – a Retrospective Study
Objective: This study aimed at further characterizing the gait of patients with clinically suspected Normal Pressure Hydrocephalus (NPH) by investigating changes in several gait domains…Serotonin Transporter Dynamics in Multiple System Atrophy: Insights from 123I-FP-CIT SPECT Imaging
Objective: We aimed to visualize a serotonin transporter (SERT) based on 123I-FP-CIT SPECT, and assessing the binding distribution characteristics of the brainstems between patients with…
- « Previous Page
- 1
- …
- 108
- 109
- 110
- 111
- 112
- …
- 181
- Next Page »